Detalhe da pesquisa
1.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
N Engl J Med
; 387(21): 1923-1934, 2022 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342113
2.
Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials.
Lancet
; 401(10384): 1293-1301, 2023 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36893777
3.
Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1ß, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker Substudy.
Circulation
; 146(5): 372-379, 2022 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762321
4.
Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy.
Eur Heart J
; 43(46): 4832-4844, 2022 12 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943897
5.
Low-Dose Methotrexate for the Prevention of Atherosclerotic Events.
N Engl J Med
; 380(8): 752-762, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30415610
6.
The neutrophil-lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials.
Eur Heart J
; 42(9): 896-903, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33417682
7.
Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trial.
Rheumatology (Oxford)
; 60(6): 2963-2968, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34144603
8.
Effects of Interleukin-1ß Inhibition on Incident Anemia: Exploratory Analyses From a Randomized Trial.
Ann Intern Med
; 172(8): 523-532, 2020 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32203978
9.
Adverse Effects of Low-Dose Methotrexate: A Randomized Trial.
Ann Intern Med
; 172(6): 369-380, 2020 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066146
10.
Residual inflammatory risk associated with interleukin-18 and interleukin-6 after successful interleukin-1ß inhibition with canakinumab: further rationale for the development of targeted anti-cytokine therapies for the treatment of atherothrombosis.
Eur Heart J
; 41(23): 2153-2163, 2020 06 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504417
11.
Comparison of interleukin-6, C-reactive protein, and low-density lipoprotein cholesterol as biomarkers of residual risk in contemporary practice: secondary analyses from the Cardiovascular Inflammation Reduction Trial.
Eur Heart J
; 41(31): 2952-2961, 2020 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32221587
12.
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
N Engl J Med
; 377(12): 1119-1131, 2017 09 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28845751
13.
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial.
Lancet
; 391(10118): 319-328, 2018 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29146124
14.
Relationship of Interleukin-1ß Blockade With Incident Gout and Serum Uric Acid Levels: Exploratory Analysis of a Randomized Controlled Trial.
Ann Intern Med
; 169(8): 535-542, 2018 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30242335
15.
Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
Eur Heart J
; 39(38): 3499-3507, 2018 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30165610
16.
Effect of interleukin-1ß inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
Lancet
; 390(10105): 1833-1842, 2017 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28855077
17.
The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials.
Eur Heart J
; 36(24): 1536-46, 2015 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-25802390
18.
Effects of multivitamin supplement on cataract and age-related macular degeneration in a randomized trial of male physicians.
Ophthalmology
; 121(2): 525-34, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24268861
19.
Effect of canakinumab on frailty: A post hoc analysis of the CANTOS trial.
Aging Cell
; 23(1): e14029, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37927208
20.
Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial.
Lancet
; 380(9841): 565-71, 2012 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22883507